About PT. Kalbe Farma Tbk.
PT Kalbe Farma Tbk. (“Kalbe”) is one of the largest publicly-listed pharmaceutical companies in Southeast Asia. Kalbe has a broad and strong portfolio of brands in prescription pharmaceuticals (Cefspan, Brainact, Broadced, etc), OTC pharmaceuticals (Woods, Promag, Mixagrip, Komix, etc), ready-to-drink products (Hydro Coco, Extra Joss, Nitros) and nutritional products (Milna, Prenagen, Diabetasol, etc), complemented with a robust distribution arm covering much of the Indonesian archipelago. Since 1991, Kalbe’s shares have been listed on the Indonesia Stock Exchange (IDX: KLBF).
For more information please contact Dave McGuigan at dmcguigan (at) stemedica (dot) com.
Read the full story at http://www.prweb.com/releases/stemedica-stem-cells/kalbe-asia-licensing/prweb10613321.htm.
Copyright©2012 Vocus, Inc.
All rights reserved